Нейропатии

68. Bosch, E. P., and Smith, B. E. Peripheral neuropathies associated with monoclonal proteins. Med. Clin. North Am. 77(1):125, 1993.

69. Dyck, P. J., et. al. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N. Engl. J. Med. 325(21): 1482, 1991.

70. Gracey, D. R., et al. Respiratory failure in Guillain-Barre syndrome: A six-year experience. Mayo Clin. Proc. 57:742, 1982.

71. The Guillain-Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 35:1096, 1985.

72. Jenkins, D., et al. Leprotic involvement of peripheral nerves in the absence of skin lesions: Case report and literature review. J. Am. Acad. Dermatol. 23 (5, Pt 2):1023, 1990.

73. Leneman, F. The Guillain-Barre syndrome: Definition, etiology, and review of 1100 cases. Arch. Intern. Med. 118:139, 1966.

74. Levinson, A. I. The use of IVIG in neurological disease. Clin. Rev. Allergy 10(1—2):119, 1992.

75. Mollman, J. E. Neuromuscular toxicity of therapy. Curr. Opin. Oncol. 4(3):540, 1992.

76. Pleasure, D. E., Lovelace, R. E., and Duvoisin, R. C. The prognosis of acute polyradiculoneuritis. Neurology (Minneapolis) 18:1143, 1968.

77. Shevell, M., et al. Congenital inflammatory myopathy. Neurology 40(7):1111, 1990.

78. Simpson, D. M., and Olney, R. K. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol. Clin. 10(3):685, 1992.

79. Soueidan, S. A., and Dalakas, M. C. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr. Res. 33(Suppl. 1):S95, 1993.

80. Van der Meche, F. G. A., Schmitz, P. I. M., and the Dutch-Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N. Engl. J. Med. 326(17): 1123, 1992.

81. Yu, R. K., et al. Autoimmune mechanisms in peripheral neuropathies. Ann. Neurol. 27(Suppl.):S30, 1990.